You are viewing the site in preview mode

Skip to main content

Table 2 Estimated Japanese disability weights (95% uncertainty interval), compared to the GBD 2013 disability weights

From: How do Japanese rate the severity of different diseases and injuries?—an assessment of disability weights for 231 health states by 37,318 Japanese respondents

Id Health state Japanese DW GBD 2013 DW [11] Factor of two or greater difference Factor of three or greater difference
Infectious disease
1 Infectious disease, acute episode, mild 0.012 (0.005–0.022) 0.006 (0.002–0.012)   
2 Infectious disease, acute episode, moderate 0.424 (0.289–0.577) 0.051 (0.032–0.074) Japan > GBD Japan > GBD
3 Infectious disease, acute episode, severe 0.242 (0.163–0.340) 0.133 (0.088–0.190)   
4 Infectious disease, post-acute consequences (fatigue, emotional lability, insomnia) 0.074 (0.047–0.106) 0.219 (0.148–0.308) Japan < GBD  
5 Diarrhea, mild 0.119 (0.079–0.165) 0.074 (0.049–0.104)   
6 Diarrhea, moderate 0.250 (0.170–0.345) 0.188 (0.125–0.264)   
7 Diarrhea, severe 0.387 (0.263–0.517) 0.247 (0.164–0.348)   
8 Epididymo-orchitis 0.204 (0.139–0.283) 0.128 (0.086–0.180)   
9 Herpes zoster 0.181 (0.123–0.257) 0.058 (0.035–0.090) Japan > GBD Japan > GBD
10 HIV cases, symptomatic, pre-AIDS 0.200 (0.140–0.275) 0.274 (0.184–0.377)   
11 HIV/AIDS cases, receiving ARV treatment 0.155 (0.108–0.219) 0.078 (0.052–0.111)   
12 AIDS cases, not receiving ARV treatment 0.394 (0.268–0.527) 0.582 (0.406–0.743)   
13 Ear pain 0.058 (0.037–0.085) 0.013 (0.007–0.024) Japan > GBD Japan > GBD
14 Tuberculosis, HIV infected 0.267 (0.181–0.372) 0.408 (0.274–0.549)   
15 Tuberculosis, not HIV infected 0.254 (0.175–0.348) 0.333 (0.224–0.454)   
Cancer
16 Cancer, diagnosis and primary therapy 0.174 (0.121–0.243) 0.288 (0.193–0.399)   
17 Cancer, metastatic 0.230 (0.158–0.312) 0.451 (0.307–0.600)   
18 Cancer, after treatment 0.079 (0.052–0.115) NA   
19 Mastectomy 0.075 (0.047–0.108) 0.036 (0.020–0.057) Japan > GBD  
20 Stoma 0.146 (0.099–0.200) 0.095 (0.063–0.131)   
21 Terminal phase, with medication (for cancers, end-stage kidney/liver disease) 0.589 (0.425–0.743) 0.540 (0.377–0.687)   
22 Terminal phase, without medication (for cancers, end-stage kidney/liver disease) 0.537 (0.378–0.693) 0.569 (0.389–0.727)   
Cardiovascular and circulatory disease
23 Acute myocardial infarction: days 1-2 0.253 (0.173–0.353) 0.432 (0.288–0.579)   
24 Acute myocardial infarction, days 3-28 0.032 (0.019–0.050) 0.074 (0.049–0.105) Japan < GBD  
25 Angina pectoris, mild 0.019 (0.010–0.033) 0.033 (0.020–0.052)   
26 Angina pectoris, moderate 0.040 (0.024–0.062) 0.080 (0.052–0.133)   
27 Angina pectoris, severe 0.163 (0.111–0.227) 0.167 (0.110–0.240)   
28 Cardiac conduction disorders and cardiac dysrhythmias 0.426 (0.297–0.561) 0.224 (0.151–0.312)   
29 Claudication 0.020 (0.011–0.034) 0.014 (0.007–0.025)   
30 Heart failure, mild 0.016 (0.008–0.028) 0.041 (0.026–0.062) Japan < GBD  
31 Heart failure, moderate 0.041 (0.025–0.061) 0.072 (0.047–0.103)   
32 Heart failure, severe 0.240 (0.166–0.336) 0.179 (0.122–0.251)   
33 Stroke: long-term consequences, mild 0.019 (0.010–0.033) 0.019 (0.010–0.032)   
34 Stroke: long-term consequences, moderate 0.044 (0.027–0.067) 0.070 (0.046–0.099)   
35 Stroke: long-term consequences, moderate plus cognition problems 0.108 (0.074–0.150) 0.316 (0.206–0.437) Japan < GBD  
36 Stroke: long-term consequences, severe 0.550 (0.386–0.701) 0.552 (0.377–0.707)   
37 Stroke: long-term consequences, severe plus cognition problems 0.579 (0.411–0.732) 0.588 (0.411–0.744)   
Diabetes and digestive and genitourinary disease
38 Diabetic foot 0.064 (0.041–0.093) 0.020 (0.010–0.034) Japan > GBD Japan > GBD
39 Diabetic neuropathy 0.098 (0.063–0.136) 0.133 (0.089–0.187)   
40 Chronic kidney disease (stage IV) 0.106 (0.070–0.151) 0.104 (0.070–0.147)   
41 End-stage renal disease, on dialysis 0.278 (0.189–0.382) 0.571 (0.398–0.725) Japan < GBD  
42 End-stage renal disease, with kidney transplant 0.018 (0.010–0.032) 0.024 (0.014–0.039)   
43 Decompensated cirrhosis of the liver 0.101 (0.067–0.144) 0.178 (0.123–0.250)   
44 Gastric bleeding 0.541 (0.387–0.690) 0.325 (0.209–0.462)   
45 Crohn’s disease or ulcerative colitis 0.219 (0.152–0.308) 0.231 (0.156–0.320)   
46 Benign prostatic hypertrophy: symptomatic 0.096 (0.064–0.136) 0.067 (0.043–0.097)   
47 Urinary incontinence 0.210 (0.143–0.292) 0.139 (0.094–0.198)   
48 Stress incontinence 0.014 (0.007–0.026) 0.020 (0.011–0.035)   
49 Impotence 0.017 (0.009–0.030) 0.017 (0.009–0.030)   
50 Infertility, primary 0.009 (0.004–0.018) 0.008 (0.003–0.015)   
51 Infertility, secondary 0.008 (0.003–0.016) 0.005 (0.002–0.011)   
Chronic respiratory disease
52 Asthma, controlled 0.006 (0.003–0.013) 0.015 (0.007–0.026) Japan < GBD  
53 Asthma, partially controlled 0.044 (0.027–0.065) 0.036 (0.022–0.055)   
54 Asthma: uncontrolled 0.212 (0.145–0.294) 0.133 (0.086–0.192)   
55 COPD and other chronic respiratory problems, mild 0.008 (0.003–0.016) 0.019 (0.007–0.026) Japan < GBD  
56 COPD and other chronic respiratory problems, moderate 0.232 (0.158–0.319) 0.225 (0.153–0.310)   
57 COPD and other chronic respiratory problems, severe 0.299 (0.203–0.405) 0.408 (0.273–0.556)   
Neurological disorders
58 Dementia, mild 0.037 (0.022–0.056) 0.069 (0.046–0.099)   
59 Dementia, moderate 0.382 (0.263–0.519) 0.377 (0.252–0.508)   
60 Dementia, severe 0.511 (0.358–0.657) 0.449 (0.304–0.595)   
61 Headache: migraine 0.518 (0.365–0.668) 0.441 (0.294–0.588)   
62 Headache: tension-type 0.109 (0.074–0.153) 0.037 (0.022–0.057) Japan > GBD  
63 Headache: medication overuse 0.185 (0.129–0.262) 0.223 (0.146–0.313)   
64 Multiple sclerosis, mild 0.235 (0.160–0.324) 0.183 (0.124–0.253)   
65 Multiple sclerosis, moderate 0.467 (0.325–0.615) 0.463 (0.313–0.613)   
66 Multiple sclerosis, severe 0.653 (0.483–0.798) 0.719 (0.534–0.858)   
67 Epilepsy, seizures ≥ once a month 0.533 (0.373–0.686) 0.552 (0.375–0.710)   
68 Epilepsy, seizures < once a month 0.396 (0.273–0.525) 0.263 (0.173–0.367)   
69 Parkinson’s disease, mild 0.016 (0.008–0.028) 0.010 (0.005–0.019)   
70 Parkinson’s disease, moderate 0.193 (0.133–0.269) 0.267 (0.181–0.372)   
71 Parkinson’s disease, severe 0.527 (0.372–0.681) 0.575 (0.396–0.730)   
Mental, behavioral, and substance use disorders
72 Alcohol use disorder, very mild 0.064 (0.040–0.092) 0.123 (0.082–0.177)   
73 Alcohol use disorder, mild 0.219 (0.151–0.306) 0.235 (0.160–0.327)   
74 Alcohol use disorder, moderate 0.312 (0.213–0.422) 0.373 (0.248–0.508)   
75 Alcohol use disorder, severe 0.413 (0.282–0.551) 0.570 (0.396–0.732)   
76 Drug dependence, mild 0.330 (0.229–0.446) NA   
77 Drug dependence 0.581 (0.419–0.740) NA   
78 Anxiety disorders, mild 0.014 (0.007–0.026) 0.030 (0.018–0.046) Japan < GBD  
79 Anxiety disorders, moderate 0.108 (0.072–0.150) 0.133 (0.091–0.186)   
80 Anxiety disorders, severe 0.376 (0.258–0.509) 0.523 (0.362–0.677)   
81 Major depressive disorder, mild episode 0.060 (0.038–0.088) 0.145 (0.099–0.209) Japan < GBD  
82 Major depressive disorder, moderate episode 0.302 (0.204–0.410) 0.396 (0.267–0.531)   
83 Major depressive disorder, severe episode 0.533 (0.378–0.680) 0.658 (0.477–0.807)   
84 Bipolar disorder: manic episode 0.321 (0.220–0.439) 0.492 (0.341–0.646)   
85 Bipolar disorder: residual state 0.031 (0.017–0.048) 0.032 (0.018–0.051)   
86 Schizophrenia: acute state 0.575 (0.408–0.733) 0.778 (0.606–0.900)   
87 Schizophrenia: residual state 0.412 (0.283–0.554) 0.588 (0.411–0.754)   
88 Anorexia nervosa 0.196 (0.137–0.272) 0.224 (0.150–0.312)   
89 Bulimia nervosa 0.280 (0.191–0.378) 0.223 (0.150–0.312)   
90 Attention deficit hyperactivity disorder 0.052 (0.032–0.076) 0.045 (0.028–0.066)   
91 Conduct disorder 0.243 (0.167–0.332) 0.241 (0.159–0.341)   
92 Asperger’s syndrome 0.099 (0.065–0.142) 0.104 (0.071–0.147)   
93 Autism 0.176 (0.122–0.245) 0.262 (0.176–0.365)   
94 Intellectual disability, borderline 0.014 (0.006–0.024) 0.011 (0.005–0.020)   
95 Intellectual disability, mild 0.047 (0.030–0.071) 0.043 (0.026–0.064)   
96 Intellectual disability, moderate 0.074 (0.047–0.108) 0.100 (0.066–0.142)   
97 Intellectual disability, severe 0.122 (0.083–0.172) 0.160 (0.107–0.266)   
98 Intellectual disability, profound 0.230 (0.159–0.317) 0.200 (0.133–0.283)   
Hearing and vision loss
99 Hearing loss, mild 0.027 (0.015–0.044) 0.010 (0.004–0.019) Japan > GBD  
100 Hearing loss, moderate 0.038 (0.023–0.057) 0.027 (0.015–0.042)   
101 Hearing loss, severe 0.208 (0.143–0.294) 0.158 (0.105–0.227)   
102 Hearing loss, profound 0.241 (0.167–0.338) 0.204 (0.134–0.288)   
103 Hearing loss, complete 0.300 (0.206–0.409) 0.215 (0.144–0.307)   
104 Hearing loss, mild, with ringing 0.047 (0.029–0.069) 0.021 (0.012–0.036) Japan > GBD  
105 Hearing loss, moderate, with ringing 0.119 (0.080–0.166) 0.031 (0.019–0.049) Japan > GBD Japan > GBD
106 Hearing loss, severe, with ringing 0.280 (0.193–0.386) 0.261 (0.175–0.360)   
107 Hearing loss, profound, with ringing 0.307 (0.214–0.414) 0.277 (0.182–0.387)   
108 Hearing loss, complete, with ringing 0.379 (0.266–0.514) 0.316 (0.212–0.435)   
109 Distance vision, mild impairment 0.005 (0.002–0.012) 0.003 (0.001–0.007)   
110 Distance vision, moderate impairment 0.051 (0.032–0.074) 0.031 (0.019–0.049)   
111 Distance vision, severe impairment 0.378 (0.266–0.514) 0.184 (0.124–0.260) Japan > GBD  
112 Distance vision blindness 0.427 (0.299–0.570) 0.187 (0.124–0.260) Japan > GBD  
113 Near vision impairment 0.012 (0.006–0.023) 0.011 (0.005–0.020)   
Musculoskeletal disorders
114 Low back pain, mild 0.028 (0.016–0.045) 0.020 (0.011–0.035)   
115 Low back pain, moderate 0.069 (0.044–0.100) 0.054 (0.035–0.079)   
116 Back pain, severe, without leg pain 0.190 (0.132–0.263) 0.272 (0.182–0.373)   
117 Back pain, severe, with leg pain 0.276 (0.190–0.381) 0.325 (0.219–0.446)   
118 Back pain, most severe, without leg pain 0.200 (0.141–0.274) 0.367 (0.227–0.523)   
119 Back pain, most severe, with leg pain 0.276 (0.186–0.379) 0.379 (0.236–0.540)   
120 Neck pain, mild 0.039 (0.023–0.058) 0.053 (0.034–0.078)   
121 Neck pain, moderate 0.063 (0.041–0.091) 0.114 (0.075–0.162)   
122 Neck pain, severe 0.169 (0.115–0.236) 0.229 (0.153–0.317)   
123 Neck pain, most severe 0.144 (0.099–0.200) 0.304 (0.202–0.415) Japan < GBD  
124 Musculoskeletal problems, lower limbs, mild 0.091 (0.060–0.129) 0.023 (0.013–0.037) Japan > GBD Japan > GBD
125 Musculoskeletal problems, lower limbs, moderate 0.142 (0.098–0.196) 0.079 (0.054–0.110)   
126 Musculoskeletal problems, lower limbs, severe 0.327 (0.223–0.438) 0.165 (0.112–0.232)   
127 Musculoskeletal problems, upper limbs, mild 0.039 (0.023–0.058) 0.028 (0.017–0.045)   
128 Musculoskeletal problems, upper limbs, moderate 0.223 (0.153–0.307) 0.117 (0.080–0.163)   
129 Musculoskeletal problems, generalized, moderate 0.255 (0.177–0.352) 0.317 (0.216–0.440)   
130 Musculoskeletal problems, generalized, severe 0.420 (0.293–0.560) 0.581 (0.403–0.739)   
131 Grout: Acute 0.322 (0.221–0.436) 0.295 (0.196–0.409)   
Injury
132 Amputation of finger(s), excluding thumb 0.063 (0.041–0.092) 0.005 (0.002–0.010) Japan > GBD Japan > GBD
133 Amputation of thumb (long term) 0.093 (0.061–0.132) 0.011 (0.005–0.021) Japan > GBD Japan > GBD
134 Amputation of one upper limb (with treatment) 0.144 (0.096–0.205) 0.039 (0.024–0.059) Japan > GBD Japan > GBD
135 Amputation of one upper limb (long term, without treatment) 0.261 (0.182–0.357) 0.118 (0.079–0.167) Japan > GBD  
136 Amputation of both upper limbs (long term, with treatment) 0.193 (0.132–0.274) 0.123 (0.081–0.176)   
137 Amputation of both upper limbs (long term, without treatment) 0.422 (0.295–0.562) 0.383 (0.251–0.525)   
138 Amputation of toe 0.080 (0.052–0.114) 0.006 (0.002–0.012) Japan > GBD Japan > GBD
139 Amputation of one lower limb (long term, with treatment) 0.096 (0.062–0.140) 0.039 (0.023–0.059) Japan > GBD  
140 Amputation of one lower limb (long term, without treatment) 0.233 (0.162–0.318) 0.173 (0.118–0.240)   
141 Amputation of both lower limbs (long term, with treatment) 0.146 (0.101–0.203) 0.088 (0.057–0.124)   
142 Amputation of both lower limbs (long term, without treatment) 0.525 (0.377–0.681) 0.443 (0.297–0.589)   
143 Burns, <20% total burned surface area or < 10% total burned surface area if head/neck or hands/wrist involved (long term, with or without treatment) 0.018 (0.009–0.031) 0.016 (0.008–0.032)   
144 Burns, ≥20% total burned surface area (short term, with or without treatment) 0.208 (0.140–0.302) 0.314 (0.211–0.441)   
145 Burns, ≥20% total burned surface area or ≥10% total burned surface area if head/neck or hands/wrist involved (long term, with treatment) 0.126 (0.085–0.176) 0.135 (0.092–0.190)   
146 Burns, ≥20% total burned surface area or ≥10% total burned surface area if head/neck or hands/wrist involved (long term, without treatment) 0.396 (0.274–0.534) 0.455 (0.302–0.601)   
147 Crush injury (short or long term, with or without treatment) 0.185 (0.129–0.257) 0.132 (0.089–0.189)   
148 Dislocation of hip (long term, with or without treatment) 0.035 (0.021–0.053) 0.016 (0.008–0.028) Japan > GBD  
149 Dislocation of knee (long term, with or without treatment) 0.252 (0.174–0.347) 0.113 (0.075–0.160) Japan > GBD  
150 Dislocation of shoulder (long term, with or without treatment) 0.132 (0.091–0.187) 0.062 (0.041–0.088) Japan > GBD  
151 Other injuries of muscle and tendon (includes sprains, strains and dislocations other than shoulder, knee, hip) 0.032 (0.018–0.049) 0.008 (0.003–0.015) Japan > GBD Japan > GBD
152 Drowning and nonfatal submersion (short or long term, with or without treatment) 0.079 (0.052–0.114) 0.247 (0.164–0.341) Japan < GBD Japan < GBD
153 Fracture of clavicle, scapula or humerus (short or long term, with or without treatment) 0.159 (0.106–0.222) 0.035 (0.021–0.053) Japan > GBD Japan > GBD
154 Fracture of face bone (short or long term with or without treatment) 0.184 (0.128–0.259) 0.067 (0.044–0.097) Japan > GBD  
155 Fracture of foot bones (short term, with or without treatment) 0.094 (0.062–0.132) 0.026 (0.015–0.043) Japan > GBD Japan > GBD
156 Fracture of foot bones (long term, without treatment) 0.045 (0.027–0.066) 0.026 (0.015–0.042)   
157 Fracture of hand (short term, with or without treatment) 0.041 (0.025–0.062) 0.010 (0.005–0.019) Japan > GBD Japan > GBD
158 Fracture of hand (long term, without treatment) 0.037 (0.022–0.058) 0.014 (0.007–0.025) Japan > GBD  
159 Fracture of neck of femur (short term, with or without treatment) 0.321 (0.218–0.437) 0.258 (0.172–0.356)   
160 Fracture of neck of femur (long term, with treatment) 0.120 (0.079–0.168) 0.058 (0.038–0.084) Japan > GBD  
161 Fracture of neck of femur (long term, without treatment) 0.375 (0.260–0.502) 0.402 (0.269–0.541)   
162 Fracture, other than femoral neck (short term, with or without treatment) 0.233 (0.159–0.324) 0.111 (0.074–0.156) Japan > GBD  
163 Fracture, other than femoral neck (long term, without treatment) 0.079 (0.052–0.113) 0.042 (0.027–0.063)   
164 Fracture of patella, tibia or fibula or ankle (short term, with or without treatment) 0.213 (0.143–0.294) 0.050 (0.032–0.075) Japan > GBD Japan > GBD
165 Fracture of patella, tibia or fibula or ankle (long term, with or without treatment) 0.122 (0.083–0.170) 0.055 (0.036–0.081) Japan > GBD  
166 Fracture of pelvis (short term) 0.431 (0.296–0.577) 0.279 (0.188–0.384)   
167 Fracture of pelvis (long term) 0.143 (0.098–0.204) 0.182 (0.123–0.253)   
168 Fracture of radius or ulna (short term, with or without treatment) 0.081 (0.054–0.118) 0.028 (0.016–0.046) Japan > GBD  
169 Fracture of radius or ulna (long term, without treatment) 0.079 (0.052–0.111) 0.043 (0.028–0.064)   
170 Fracture of skull (short or long term, with or without treatment) 0.132 (0.087–0.190) 0.071 (0.048–0.100)   
171 Fracture of sternum and/or fracture of one or two ribs (short term, with or without treatment) 0.170 (0.116–0.238) 0.103 (0.068–0.145)   
172 Fracture of vertebral column (short or long term, with or without treatment) 0.106 (0.070–0.147) 0.111 (0.075–0.156)   
173 Fractures, treated (long term) 0.008 (0.003–0.017) 0.005 (0.002–0.014)   
174 Injured nerves (short term) 0.237 (0.157–0.329) 0.100 (0.067–0.140) Japan > GBD  
175 Injured nerves (long term) 0.161 (0.111–0.223) 0.113 (0.076–0.157)   
176 Injury to eyes (short term) 0.076 (0.049–0.109) 0.054 (0.035–0.081)   
177 Concussion 0.170 (0.112–0.244) 0.110 (0.074–0.158)   
178 Severe traumatic brain injury, short term (with or without treatment) 0.114 (0.075–0.162) 0.214 (0.141–0.297)   
179 Traumatic brain injury, long-term consequences, minor (with or without treatment) 0.192 (0.132–0.266) 0.094 (0.063–0.133) Japan > GBD  
180 Traumatic brain injury, long-term consequences, moderate (with or without treatment) 0.212 (0.144–0.299) 0.231 (0.156–0.324)   
181 Traumatic brain injury, long-term consequences, severe (with or without treatment) 0.455 (0.315–0.600) 0.637 (0.462–0.789)   
182 Open wound (short term, with or without treatment) 0.035 (0.021–0.055) 0.006 (0.002–0.012) Japan > GBD Japan > GBD
183 Poisoning (short term with or without treatment) 0.276 (0.193–0.377) 0.163 (0.109–0.227)   
184 Severe chest injury (long term, with or without treatment) 0.065 (0.042–0.095) 0.047 (0.030–0.070)   
185 Severe chest injury (short term, with or without treatment) 0.220 (0.152–0.306) 0.369 (0.248–0.501)   
186 Spinal cord lesion below neck level (treated) 0.388 (0.270–0.524) 0.296 (0.198–0.414)   
187 Spinal cord lesion below neck level (untreated) 0.564 (0.404–0.722) 0.623 (0.434–0.777)   
188 Spinal cord lesion at neck level (treated) 0.637 (0.468–0.792) 0.589 (0.415–0.748)   
189 Spinal cord lesion at neck level (untreated) 0.707 (0.527–0.842) 0.732 (0.544–0.871)   
Other
190 Abdominopelvic problem, mild 0.029 (0.016–0.046) 0.011 (0.005–0.021) Japan > GBD  
191 Abdominopelvic problem, moderate 0.392 (0.270–0.524) 0.114 (0.078–0.159) Japan > GBD Japan > GBD
192 Abdominopelvic problem, severe 0.339 (0.235–0.458) 0.324 (0.220–0.442)   
193 Anemia, mild 0.004 (0.001–0.009) 0.004 (0.001–0.008)   
194 Anemia, moderate 0.064 (0.040–0.092) 0.052 (0.034–0.076)   
195 Anemia, severe 0.040 (0.024–0.061) 0.149 (0.101–0.209) Japan < GBD Japan < GBD
196 Periodontitis 0.008 (0.003–0.015) 0.007 (0.003–0.014)   
197 Dental caries: symptomatic 0.035 (0.021–0.053) 0.010 (0.005–0.019) Japan > GBD Japan > GBD
198 Severe tooth loss 0.082 (0.053–0.115) 0.067 (0.045–0.095)   
199 Disfigurement: level 1 0.043 (0.026–0.063) 0.011 (0.005–0.021) Japan > GBD Japan > GBD
200 Disfigurement: level 2 0.123 (0.083–0.171) 0.067 (0.044–0.096)   
201 Disfigurement: level 3 0.512 (0.362–0.670) 0.405 (0.275–0.546)   
202 Generic uncomplicated disease: worry and daily medication 0.016 (0.008–0.028) 0.049 (0.031–0.072) Japan < GBD Japan < GBD
203 Generic uncomplicated disease: anxiety about diagnosis 0.008 (0.003–0.015) 0.012 (0.006–0.023)   
204 Severe wasting 0.086 (0.056–0.124) 0.128 (0.082–0.183)   
205 Speech problems 0.065 (0.041–0.094) 0.051 (0.032–0.078)   
206 Motor impairment, mild 0.009 (0.004–0.016) 0.010 (0.005–0.019)   
207 Motor impairment, moderate 0.045 (0.028–0.065) 0.061 (0.040–0.089)   
208 Motor impairment, severe 0.294 (0.202–0.396) 0.402 (0.268–0.545)   
209 Motor plus cognitive impairments, mild 0.023 (0.013–0.038) 0.031 (0.018–0.050)   
210 Motor plus cognitive impairments, moderate 0.106 (0.069–0.150) 0.203 (0.134–0.290)   
211 Motor plus cognitive impairments, severe 0.457 (0.318–0.606) 0.542 (0.374–0.702)   
212 Thrombocytopenic purpura 0.110 (0.073–0.154) 0.159 (0.106–0.226)   
213 Hypothyroidism 0.012 (0.005–0.023) 0.019 (0.010–0.032)   
214 Hyperthyroidism 0.103 (0.069–0.146) 0.145 (0.096–0.202)   
215 Vertigo and balance disorder (Menière, labyrinthitis) 0.102 (0.069–0.145) 0.113 (0.074–0.158)   
216 Allergic rhinitis (hay fever) 0.009 (0.004–0.016) 0.007 (0.003–0.017)   
217 Borderline personality disorder 0.132 (0.091–0.186) 0.190 (0.120–0.262)   
218 Carpal tunnel syndrome 0.020 (0.011–0.034) 0.035 (0.023–0.055)   
219 Constipation 0.048 (0.030–0.070) 0.061 (0.040–0.093)   
220 Hemorrhoids 0.090 (0.058–0.127) 0.109 (0.072–0.154)   
221 Heart burn and reflux “GERD” 0.046 (0.029–0.069) 0.027 (0.015–0.046)   
222 Insomnia 0.036 (0.022–0.055) 0.016 (0.009–0.031) Japan > GBD  
223 Intensive care unit admission 0.675 (0.506–0.822) 0.739 (0.526–0.891)   
224 Invasive device/drain 0.512 (0.362–0.664) 0.143 (0.095–0.207) Japan > GBD Japan > GBD
225 Irritable bowel syndrome 0.039 (0.024–0.059) 0.064 (0.040–0.093)   
226 Sleep apnea 0.024 (0.014–0.040) 0.032 (0.020–0.051)   
227 Somatoform disorder 0.060 (0.038–0.086) 0.140 (0.095–0.199) Japan < GBD  
228 Varicose veins 0.018 (0.010–0.031) 0.020 (0.010–0.037)   
229 Trigeminal neuralgia 0.128 (0.086–0.181) 0.068 (0.045–0.101)   
230 Vaginal discharge 0.096 (0.062–0.135) NA   
231 Dermatitis 0.079 (0.050–0.115) NA   
  1. GBD Global Burden of Disease study, DW Disability weigh
Back to article page

Population Health Metrics

ISSN: 1478-7954